MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » St. Jude Medical settles Riata, shareholder suits for $64m

St. Jude Medical settles Riata, shareholder suits for $64m

By

St. Jude Medical settles Riata, shareholder lawsuits for $64m

St. Jude Medical (NYSE:STJ) said it settled a raft of product liability lawsuits filed over its Riata and Riata ST defibrillator leads and agreed with shareholders to close out a class action lawsuit brought over its 3rd-quarter 2009 results.

Taken together the settlements are worth nearly $64.3 million, including $14.3 million for the Riata cases and $50 million for the shareholders lawsuit, according to a regulatory filing.

St. Jude pulled the silicone-coated Riata and Riata ST leads in 2010 after finding that some of the internal conductors had worn through their insulation, a failure that could result in patients receiving unwanted shocks. In November 2011 the company warned that the Riata leads appeared to fail more frequently than previously reported, leading to a Class I recall from the FDA.

Yesterday the company said it agreed to settle all but 3 of the nearly 1,000 Riata cases it’s facing, without admitting any liability, and said it put aside $15 million during Q4 2014 to cover the deal.

"Patient safety is St. Jude Medical’s highest priority. The company remains dedicated to developing technology and products that save and improve the lives of patients around the world," St. Jude said in a statement. "In the interest of patient safety and continued transparency surrounding data from the company’s silicone-only leads, St. Jude Medical continues to communicate regularly with physicians about long-term performance of implanted Riata leads through a semi-annual product performance report and through www.riatacommunication.com, a dedicated resource for providing the latest information on Riata leads."

St. Jude also said it agreed to pay $50 million to settle a lawsuit filed in March 2010 alleging that it concealed evidence of slowing demand and lower orders for its cardiac rhythm management products before it lowered its guidance after the 3rd quarter of 2009. St. Jude moved to have the suit tossed in 2013, arguing that the plaintiffs "cannot prove the allegations of ‘fraud’ in their complaint."

Yesterday the company said it agreed to settle the class action case, agreeing to a $50 million payment pending preliminary approval by the U.S. District Court for Minnesota, where a hearing is slated for March 12. St. Jude said it recognized probable insurance recoveries of $30 million for case and "intends to pursue collection of additional insurance recoveries from certain of its insurance carriers."

In case you missed it

RSS From Medical Design & Outsourcing

  • Medtronic’s recall of HawkOne system is Class I
    The FDA today issued a notice confirming that the recall of Medtronic’s (NYSE:MDT) HawkOne system is Class I, the most serious kind. So far in 2022, the FDA has classified three Medtronic-related recalls as Class I, with the Covidien (part of Medtronic) Puritan Bennett 980 series ventilator and the Synergy Cranial and StealthStation S7 Cranial software receiving the same classification earlier… […]
  • January 2022 Issue: The pandemic tested Metronic’s mettle
      The pandemic tested Medtronic’s mettle: Its CFO explains how How Abbott seeks to improve care, health inequities for people with cardiovascular disease Medtech’s biggest personnel changes in 2021 The top 5 medtech news stories of 2021 Some thoughts for medtech leaders in 2022 Starting our third year of the COVID-19 pandemic, I wonder when… […]
  • Feinstein Institutes researchers develop tiny implantable neurostimulator for mouse studies
    Researchers have developed a novel, fully implantable wireless bidirectional vagus nerve stimulation (VNS) and sensing device for mice. Engineers and researchers at the Institute of Bioelectronic Medicine at The Feinstein Institutes for Medical Research published details about the device and its capabilities in Biosensors and Bioelectronics. They think the device has the potential to transform how… […]
  • MIT team working on all-in-one diabetes management devices
    MIT researchers are touting a platform aimed at helping patients maintain healthy glucose levels by streamlining the diabetes management process. The MIT researchers say it’s hard for people with diabetes to maintain a treatment regimen. Typically at every meal, they need to estimate carbohydrate content, draw blood to measure blood glucose levels, and calculate the… […]
  • Element expands life sciences testing business with pharma, biotech capabilities
    Element Materials Technology recently announced that with the completed acquisition of JMI Laboratories in 2021, it has built out its life sciences testing capabilities for the pharmaceutical and biopharmaceutical industries. The acquisition added more than 1,000 experts in 23 facilities in North America and Europe and marked a strategic shift for the London-based company to… […]
  • Team Technologies acquires consumable medical device manufacturer iiMed
    Team Technologies recently announced that it acquired consumable medical device manufacturer iiMed Medical Solutions for an undisclosed amount. The acquisition is the fourth purchase since Clearlake Capital Group invested in the company in 2018. It is the eighth transaction completed by the company since 2012. Nearshore specialty manufacturer iiMed makes FDA Class I and Class… […]
  • P-Duke Technology is selling dc/dc converters for medical
    P-Duke Technology is promoting its MPS and MPH series of medical dc/dc converters. The MPS and MPH series comply with Medical EN60601-1 and I.T.E. EN 62368-1 certifications, according to the company. They provide 2W and 3.5W output power, 2:1 input range, regulated 5, 9, 12, 15, 24, ±12, ±15 VDC output voltage, and both DIP16… […]
  • Philips backing efforts to reduce CIED infections
    Royal Philips (NYSE:PHG) announced today that it supports the American Heart Association’s efforts to reduce CIED infections. Amsterdam-based Philips offered its support to the initiative to generate awareness among cross-disciplinary specialties and improve survival rates from CIED (cardiovascular implantable electronic device) infections. The company said in a news release that, with its support, the American… […]
  • Democratic senator wants COVID-19 test-makers to lower prices
    Sen. Ed Markey, D-Massachusetts, has sent letters to CEOs of at-home COVID-19 test-makers, asking why tests are selling for as much as $12 apiece. In a letter sent today to Abbott CEO Robert Ford, for example, Markey cited a Reuters story from October 2021 in which British test-maker Mologic said that rapid antigen tests can… […]
  • These medtech companies care a lot about research
    They’re making glaucoma-treating stents, tumor-treating fields, coin-sized CGMs and more. Discover the medtech companies that spend the most on research as a percentage of revenue. The list comes from our annual Big 100 report, which examines the world’s 100 largest medical device companies and ranks them by revenue. (Check out our full Big 100 report… […]
  • Traco Power launches new AC/DC power supplies
    Traco Power (Baar, Switzerland) announced its newest high efficiency, miniaturized ac/dc power supplies: the TPP 180 series for medical and industrial and TPI 180 for industrial. The power supplies measure only 2-by-3-by-1.24 inches in the open frame version — with global safety approvals for medical or industrial markets. They come in16 standard models with single… […]

Leave a Reply